Basal cell carcinoma: Epidemiology, clinical and histologic features, and basic science overview

Current Problems in Cancer

Volumn 39, Issue 4, 2015, Pages 198-205

  Prieto Granada, Carlos ^a   Rodriguez Waitkus, Paul ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BASAL CELL CARCINOMA; CANCER CLASSIFICATION; CLINICAL FEATURE; HISTOPATHOLOGY; HUMAN; NON MELANOMA SKIN CANCER; PATHOGENESIS; CARCINOMA, BASAL CELL; PATHOLOGY; SKIN; SKIN NEOPLASMS;

CARCINOMA, BASAL CELL; HUMANS; SKIN; SKIN NEOPLASMS;

EID: 84941317683     PISSN: 01470272     EISSN: 15356345     Source Type: Journal    
DOI: 10.1016/j.currproblcancer.2015.07.004     Document Type: Article

References (78)

1. Silverberg E., Boring C.C., Squires T.S. Cancer statistics, 1990. CA Cancer J Clin 1990, 40(1):9-26.
2. Miller D.L., Weinstock M.A. Nonmelanoma skin cancer in the United States: incidence. J Am Acad Dermatol 1994, 30(5 Pt 1):774-778.
3. Gallagher R.P., Hill G.B., Bajdik C.D., et al. Sunlight exposure, pigmentary factors, and risk of nonmelanocytic skin cancer. I. Basal cell carcinoma. Arch Dermatol 1995, 131(2):157-163.
4. Marks R. An overview of skin cancers. Incidence and causation. Cancer 1995, 75(2 Suppl):607-612.
5. Madan V., Lear J.T., Szeimies R.M. Non-melanoma skin cancer. Lancet 2010, 375(9715):673-685.
6. Jemal A., Siegel R., Ward E., et al. Cancer statistics, 2008. CA Cancer J Clin 2008, 58(2):71-96.
7. Lomas A., Leonardi-Bee J., Bath-Hextall F. A systematic review of worldwide incidence of nonmelanoma skin cancer. Br J Dermatol 2012, 166(5):1069-1080.
8. Staples M.P., Elwood M., Burton R.C., et al. Non-melanoma skin cancer in Australia: the 2002 national survey and trends since 1985. Med J Aust 2006, 184(1):6-10.
9. Horay P., Duperrat-Noury G. Puissant A. Basal-cell carcinoma in the youthful: report of a case in a young woman. J Dermatol Surg Oncol 1979, 5(8):632-634.
10. Rahbari H., Mehregan A.H. Basal cell epithelioma (carcinoma) in children and teenagers. Cancer 1982, 49(2):350-353.
11. Cox N.H. Basal cell carcinoma in young adults. Br J Dermatol 1992, 127(1):26-29.
12. LeSueur B.W., Silvis N.G., Hansen R.C. Basal cell carcinoma in children: report of 3 cases. Arch Dermatol 2000, 136(3):370-372.
13. Griffin J.R., Cohen P.R., Tschen J.A., et al. Basal cell carcinoma in childhood: case report and literature review. J Am Acad Dermatol 2007, 57(5 Suppl):S97-S102.
14. Ademiluyi S.A., Ijaduola G.T. Occurrence and recurrence of basal cell carcinoma of the head and neck in Negroid and albinoid Africans. J Laryngol Otol 1987, 101(12):1324-1328.
15. Dinehart S.M., Dodge R., Stanley W.E., et al. Basal cell carcinoma treated with Mohs surgery. A comparison of 54 younger patients with 1050 older patients. J Dermatol Surg Oncol 1992, 18(7):560-566.
16. Gorlin R.J. Nevoid basal-cell carcinoma syndrome. Medicine (Baltimore) 1987, 66(2):98-113.
17. Cohen P.R. Genodermatoses with malignant potential. Am Fam Physician 1992, 46(5):1479-1486.
18. Varan A., Gokoz A., Akyuz C., et al. Primary malignant skin tumors in children: etiology, treatment and prognosis. Pediatr Int 2005, 47(6):653-657.
19. Boyd A.S., Shyr Y., King L.E. Basal cell carcinoma in young women: an evaluation of the association of tanning bed use and smoking. J Am Acad Dermatol 2002, 46(5):706-709.
20. Karagas M.R., Zens M.S., Li Z., et al. Early-onset basal cell carcinoma and indoor tanning: a population-based study. Pediatrics 2014, 134(1):e4-e12.
21. Kempf W., Mertz K.D., Hofbauer G.F., et al. Skin cancer in organ transplant recipients. Pathobiology 2013, 80(6):302-309.
22. Ramsay H.M., Fryer A., Strange R.C., et al. Multiple basal cell carcinomas in a patient with acute myeloid leukaemia and chronic lymphocytic leukaemia. Clin Exp Dermatol 1999, 24(4):281-282.
23. Brewer J.D., Shanafelt T.D., Khezri F., et al. Increased incidence and recurrence rates of nonmelanoma skin cancer in patients with non-Hodgkin lymphoma: a Rochester Epidemiology Project population-based study in Minnesota. J Am Acad Dermatol 2015, 72(2):302-309.
24. Kimonis V.E., Goldstein A.M., Pastakia B., et al. Clinical manifestations in 105 persons with nevoid basal cell carcinoma syndrome. Am J Med Genet 1997, 69(3):299-308.
25. Parren L.J., Frank J. Hereditary tumour syndromes featuring basal cell carcinomas. Br J Dermatol 2011, 165(1):30-34.
26. Ponti G., Pellacani G., Seidenari S., et al. Cancer-associated genodermatoses: skin neoplasms as clues to hereditary tumor syndromes. Crit Rev Oncol Hematol 2013, 85(3):239-256.
27. Tirado M., Stander S., Metze D. Histologic and immunohistochemical characteristics of cutaneous cysts in Goltz-Gorlin syndrome: clues for differentiation of nonsyndromic cysts. Am J Dermatopathol 2014, 36(11):892-898.
28. Abuzahra F., Parren L.J., Frank J. Multiple familial and pigmented basal cell carcinomas in early childhood-Bazex-Dupre-Christol syndrome. J Eur Acad Dermatol Venereol 2012, 26(1):117-121.
29. Ponti G., Nasti S., Losi L., et al. Brooke-Spiegler syndrome: report of two cases not associated with a mutation in the CYLD and PTCH tumor-suppressor genes. J Cutan Pathol 2012, 39(3):366-371.
30. Wadt K.A., Aoude L.G., Johansson P., et al. A recurrent germline BAP1 mutation and extension of the BAP1 tumor predisposition spectrum to include basal cell carcinoma. Clin Genet 2014, http://dx.doi.org/10.1111/cge.12501 [Epub ahead of print].
31. de la Fouchardiere A., Cabaret O., Savin L., et al. Germline BAP1 mutations predispose also to multiple basal cell carcinomas. Clin Genet 2014, http://dx.doi.org/10.1111/cge.12472 [Epub ahead of print].
32. Betti R., Bruscagin C., Inselvini E., et al. Basal cell carcinomas of covered and unusual sites of the body. Int J Dermatol 1997, 36(7):503-505.
33. Berlin J.M., Warner M.R., Bailin P.L. Metastatic basal cell carcinoma presenting as unilateral axillary lymphadenopathy: report of a case and review of the literature. Dermatol Surg 2002, 28(11):1082-1084.
34. McCusker M., Basset-Seguin N., Dummer R., et al. Metastatic basal cell carcinoma: prognosis dependent on anatomic site and spread of disease. Eur J Cancer 2014, 50(4):774-783.
35. von Domarus H., Stevens P.J. Metastatic basal cell carcinoma. Report of five cases and review of 170 cases in the literature. J Am Acad Dermatol 1984, 10(6):1043-1060.
36. Lee M.M., Wick M.M. Bowen[U+05F3]s disease. CA Cancer J Clin 1990, 40(4):237-242.
37. Crowson A.N. Basal cell carcinoma: biology, morphology and clinical implications. Mod Pathol 2006, 19(suppl 2):S127-S147.
38. McKee P.H., Calonje E., Granter S.R. Pathology of the Skin: With Clinical Correlations 2005, Philadelphia Elsevier Mosby, Edinburgh. P.H. McKee, E. Calonje, S.R. Granter (Eds.).
39. Tozawa T., Ackerman A.B. Basal cell carcinoma with follicular differentiation. Am J Dermatopathol 1987, 9(4):474-482.
40. Walsh N., Ackerman A.B. Infundibulocystic basal cell carcinoma: a newly described variant. Mod Pathol 1990, 3(5):599-608.
41. Crawford K.M., Kobayashi T. Nevoid basal cell carcinoma syndrome or multiple hereditary infundibulocystic basal cell carcinoma syndrome?. J Am Acad Dermatol 2004, 51(1):989-995.
42. Requena L., Farina M.C., Robledo M., et al. Multiple hereditary infundibulocystic basal cell carcinomas: a genodermatosis different from nevoid basal cell carcinoma syndrome. Arch Dermatol 1999, 135(8):1227-1235.
43. Belliveau M.J., Coupal D.J., Brownstein S., et al. Infundibulocystic basal cell carcinoma of the eyelid in basal cell nevus syndrome. Ophthal Plast Reconstr Surg 2010, 26(2):147-152.
44. Brownstein M.H. Basaloid follicular hamartoma: solitary and multiple types. J Am Acad Dermatol 1992, 27(5):237-240.
45. de Eusebio E., Sanchez Yus E., Lopez Bran E., et al. Infundibulocystic basaloid neoplasm. J Cutan Pathol 1996, 23(2):147-150.
46. Pinkus H. Premalignant fibroepithelial tumors of skin. AMA Arch Derm Syphilol 1953, 67(3):598-615.
47. Litzow T.J., Perry H.O., Soderstrom C.W. Morpheaform basal cell carcinoma. Am J Surg 1968, 116(7):499-505.
48. Requena L., Martin L., Farina M.C., et al. Keloidal basal cell carcinoma. A new clinicopathological variant of basal cell carcinoma. Br J Dermatol 1996, 134(6):953-957.
49. Jones M., Bresch M., Alvarez D., et al. Keloidal basal cell carcinoma: not a distinctive clinicopathological entity. Br J Dermatol 2009, 160(5):127-131.
50. Roenigk R.K., Ratz J.L., Bailin P.L., et al. Trends in the presentation and treatment of basal cell carcinomas. J Dermatol Surg Oncol 1986, 12(6):860-865.
51. Brown C.I., Perry A.E. Incidence of perineural invasion in histologically aggressive types of basal cell carcinoma. Am J Dermatopathol 2000, 22(10):123-125.
52. Salasche S.J., Amonette R.A. Morpheaform basal-cell epitheliomas. A study of subclinical extensions in a series of 51 cases. J Dermatol Surg Oncol 1981, 7(3):387-394.
53. Sloane J.P. The value of typing basal cell carcinomas in predicting recurrence after surgical excision. Br J Dermatol 1977, 96(2 Pt 1):127-132.
54. Hendrix J.D., Parlette H.L. Micronodular basal cell carcinoma. A deceptive histologic subtype with frequent clinically undetected tumor extension. Arch Dermatol 1996, 132(2):295-298.
55. Betti R., Menni S., Radaelli G., et al. Micronodular basal cell carcinoma: a distinct subtype? Relationship with nodular and infiltrative basal cell carcinomas. J Dermatol 2010, 37(6):611-616.
56. de Faria J.L., Navarrete M.A. The histopathology of the skin basal cell carcinoma with areas of intermediate differentiation. A metatypical carcinoma?. Pathol Res Pract 1991, 187(8):978-985.
57. Martin R.C., Edwards M.J., Cawte T.G., et al. Basosquamous carcinoma: analysis of prognostic factors influencing recurrence. Cancer 2000, 88(6):1365-1369.
58. Allen K.J., Cappel M.A., Killian J.M., et al. Basosquamous carcinoma and metatypical basal cell carcinoma: a review of treatment with Mohs micrographic surgery. Int J Dermatol 2014, 53(11):1395-1403.
59. Hahn H., Wicking C., Zaphiropoulous P.G., et al. Mutations of the human homolog of Drosophila patched in the nevoid basal cell carcinoma syndrome. Cell 1996, 85(6):841-851.
60. Johnson R.L., Rothman A.L., Xie J., et al. Human homolog of patched, a candidate gene for the basal cell nevus syndrome. Science 1996, 272(5268):1668-1671.
61. Epstein E.H. Basal cell carcinomas: attack of the hedgehog. Nat Rev Cancer 2008, 8(10):743-754.
62. Ashton K.J., Weinstein S.R., Maguire D.J., et al. Molecular cytogenetic analysis of basal cell carcinoma DNA using comparative genomic hybridization. J Invest Dermatol 2001, 117(3):683-686.
63. Teh M.T., Blaydon D., Chaplin T., et al. Genomewide single nucleotide polymorphism microarray mapping in basal cell carcinomas unveils uniparental disomy as a key somatic event. Cancer Res 2005, 65(19):8597-8603.
64. Xie J., Murone M., Luoh S.M., et al. Activating smoothened mutations in sporadic basal-cell carcinoma. Nature 1998, 391(6662):90-92.
65. Smith M.J., Beetz C., Williams S.G., et al. Germline mutations in SUFU cause Gorlin syndrome-associated childhood medulloblastoma and redefine the risk associated with PTCH1 mutations. J Clin Oncol 2014, 32(36):4155-4161.
66. Proctor A.E., Thompson L.A., O'Bryant C.L. Vismodegib: an inhibitor of the Hedgehog signaling pathway in the treatment of basal cell carcinoma. Ann Pharmacother 2014, 48(1):99-106.
67. Poulalhon N., Dalle S., Balme B., et al. Fast-growing cutaneous squamous cell carcinoma in a patient treated with vismodegib. Dermatology 2015.
68. Saintes C., Saint-Jean M., Brocard A., et al. Development of squamous cell carcinoma into basal cell carcinoma under treatment with Vismodegib. J Eur Acad Dermatol Venereol 2015, 29(5):1006-1009.
69. Zhu G.A., Sundram U., Chang A.L. Two different scenarios of squamous cell carcinoma within advanced Basal cell carcinomas: cases illustrating the importance of serial biopsy during vismodegib usage. JAMA Dermatol 2014, 150(9):970-973.
70. Iarrobino A., Messina J.L., Kudchadkar R., et al. Emergence of a squamous cell carcinoma phenotype following treatment of metastatic basal cell carcinoma with vismodegib. J Am Acad Dermatol 2013, 69(1):e33-e34.
71. Sharpe H.J., Pau G., Dijkgraaf G.J., et al. Genomic analysis of smoothened inhibitor resistance in Basal cell carcinoma. Cancer Cell 2015, 27(3):327-341.
72. Ling G., Persson A., Berne B., et al. Persistent p53 mutations in single cells from normal human skin. Am J Pathol 2001, 159(4):1247-1253.
73. Ponten F., Berg C., Ahmadian A., et al. Molecular pathology in basal cell cancer with p53 as a genetic marker. Oncogene 1997, 15(9):1059-1067.
74. Reifenberger J., Wolter M., Knobbe C.B., et al. Somatic mutations in the PTCH, SMOH, SUFUH and TP53 genes in sporadic basal cell carcinomas. Br J Dermatol 2005, 152(1):43-51.
75. Tabata H., Nagano T., Ray A.J., et al. Low frequency of genetic change in p53 immunopositive clones in human epidermis. J Invest Dermatol 1999, 113(6):972-976.
76. Ziegler A., Leffell D.J., Kunala S., et al. Mutation hotspots due to sunlight in the p53 gene of nonmelanoma skin cancers. Proc Natl Acad Sci U S A 1993, 90(9):4216-4220.
77. Ling G., Ahmadian A., Persson A., et al. PATCHED and p53 gene alterations in sporadic and hereditary basal cell cancer. Oncogene 2001, 20(53):7770-7778.
78. Wetmore C., Eberhart D.E., Curran T. Loss of p53 but not ARF accelerates medulloblastoma in mice heterozygous for patched. Cancer Res 2001, 61(2):513-516.